lidocaine has been researched along with Erythema in 48 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
Erythema: Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to compare the efficacy of topical piroxicam and EMLA cream on pain control and subsequent inflammation in neodymium:yttrium-aluminum-garnet (Nd:YAG) 1,064 nm laser hair removal in female volunteers." | 9.14 | A clinical comparison of topical piroxicam and EMLA cream for pain relief and inflammation in laser hair removal. ( Akinturk, S; Eroglu, A, 2009) |
| "Pain scores with piroxicam gel were higher on cannulation and on advancement of the cannula (P < 0." | 9.10 | Piroxicam gel, compared to EMLA cream is associated with less pain after venous cannulation in volunteers. ( Dutta, A; Puri, GD; Wig, J, 2003) |
| "We found that ketoprofen (but not hydroxyzine or lidocaine) significantly attenuated tDCS-induced erythema regarding intensity and duration, with a medium effect compared with placebo." | 5.20 | Reducing transcranial direct current stimulation-induced erythema with skin pretreatment: considerations for sham-controlled clinical trials. ( Benseñor, IM; Bikson, M; Boggio, PS; Brunoni, AR; Caumo, W; Cordeiro, Q; Guarienti, F; Lotufo, PA; Shiozawa, P, 2015) |
| "The aim of this study was to compare the efficacy of topical piroxicam and EMLA cream on pain control and subsequent inflammation in neodymium:yttrium-aluminum-garnet (Nd:YAG) 1,064 nm laser hair removal in female volunteers." | 5.14 | A clinical comparison of topical piroxicam and EMLA cream for pain relief and inflammation in laser hair removal. ( Akinturk, S; Eroglu, A, 2009) |
| "To examine the efficacy and safety of a new topical anesthetic containing a disinfection ingredient (LidoDin cream) in reducing the pain associated with venipuncture by comparing it with the proven eutectic mixture of lidocaine 2." | 5.14 | Lidocaine-based topical anesthetic with disinfectant (LidoDin) versus EMLA for venipuncture: a randomized controlled trial. ( Hadash, A; Kassis, I; Knaani-Levinz, H; Shachor-Meyouhas, Y; Shavit, I, 2009) |
| "Twenty patients with localized neuropathic pain [postoperative neuropathic pain (n = 14); complex regional pain syndrome (n = 2); and postherpetic neuralgia (n = 4)], who had been successfully treated with 5% lidocaine medicated plaster, were followed up by telephone interview after 3 and 5 years." | 5.14 | Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster. ( Griessinger, N; Likar, R; Sittl, R; Tzabazis, A; Wilhelm, IR, 2010) |
| "To determine whether brief, focal pretreatment of children's skin with low-frequency ultrasound followed by a 5-minute application of a 4% lidocaine topical anesthetic decreases the pain of intravenous (IV) catheter placement." | 5.12 | Brief focal ultrasound with topical anesthetic decreases the pain of intravenous placement in children. ( Bates, A; Becker, BM; Lovgren, K; Minugh, PA; Skarbek-Borowska, S, 2006) |
| "Pain scores with piroxicam gel were higher on cannulation and on advancement of the cannula (P < 0." | 5.10 | Piroxicam gel, compared to EMLA cream is associated with less pain after venous cannulation in volunteers. ( Dutta, A; Puri, GD; Wig, J, 2003) |
| "A chart review was performed and patients who presented with erythema of face, neck, chest, and extremities pretreated with topical anesthesia (23% lidocaine/7% tetracaine ointment or 7% lidocaine/7% tetracaine ointment) undergoing PDL were reviewed and compared with another group without anesthesia." | 3.96 | The Efficacy of Pulsed Dye Laser Pretreated With or Without Local Anesthetic on Patients Presenting With Erythema of Face, Neck, Chest, and Extremities. ( Alhaddad, M; Boen, M; Chunharas, C; Wu, DC, 2020) |
| " The validity and utility of this in vivo system were demonstrated in a skin blanching/reddening experiment using epinephrine and lidocaine, and in a study measuring the severity of radiation-induced erythema during radiation therapy." | 3.80 | Inexpensive diffuse reflectance spectroscopy system for measuring changes in tissue optical properties. ( Farrell, TJ; Glennie, DL; Hayward, JE; McKee, DE, 2014) |
| "Pain and potential adverse events (AE) remain challenges for patients being treated with calcium hydroxylapatite (CaHA; Radiesse), especially CaHA not mixed with an anesthetic." | 2.79 | Safety and effectiveness of injection of calcium hydroxylapatite via blunt cannula compared to injection by needle for correction of nasolabial folds. ( Beer, KR, 2014) |
| "Flare, spontaneous pain, and primary and secondary hyperalgesia to punctate mechanical stimuli were assessed after the incision had been made." | 2.70 | Different mechanisms of development and maintenance of experimental incision-induced hyperalgesia in human skin. ( Kawamata, M; Kawamata, T; Kozuka, Y; Namiki, A; Nishikawa, K; Omote, K; Takahashi, T; Watanabe, H, 2002) |
| "Pain was evaluated on a visual analog scale (VAS, 0-10)." | 2.69 | [Efficacy of EMLA cream, effect of time and place of application]. ( Cano Serrano, ME; Martínez-Tellería, A; Rufino Ruiz, J, 1999) |
| " The most common adverse events generally involve mild skin reactions." | 2.42 | Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature. ( Alvarez, NA; Galer, BS; Gammaitoni, AR, 2003) |
| "Localized neuropathic pain (LNP) is a subgroup of neuropathic pain characterized by consistent and circumscribed area(s) of maximum pain, associated with negative or positive sensory signs and/or spontaneous symptoms characteristic of NP." | 1.48 | Efficacy of lidocaine 5% medicated plaster (VERSATIS®) in patients with localized neuropathic pain poorly responsive to pharmacological therapy. ( Chinellato, E; Del Balzo, G; Martini, A; Parolini, M; Picelli, A; Polati, E; Schweiger, V; Tamburin, S; Zanzotti, M, 2018) |
| "The Safety of Microfocused Ultrasound with Visualization (MFU-V) has been well established in both controlled clinical studies and in clinical use, showing only mild and transient anticipated side effects and only rare unanticipated adverse events (AEs)." | 1.40 | Review of the safety profile for microfocused ultrasound with visualization. ( Dobke, MK; Hitchcock, TM, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (10.42) | 18.7374 |
| 1990's | 12 (25.00) | 18.2507 |
| 2000's | 16 (33.33) | 29.6817 |
| 2010's | 13 (27.08) | 24.3611 |
| 2020's | 2 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Li, L | 1 |
| Cai, B | 1 |
| Li, H | 1 |
| Wei, J | 1 |
| Tao, L | 1 |
| Ma, P | 1 |
| Chunharas, C | 1 |
| Boen, M | 1 |
| Alhaddad, M | 1 |
| Wu, DC | 1 |
| Kwon, HJ | 1 |
| Lee, SJ | 1 |
| Kim, JM | 1 |
| Park, KY | 1 |
| Martini, A | 1 |
| Del Balzo, G | 1 |
| Schweiger, V | 1 |
| Zanzotti, M | 1 |
| Picelli, A | 1 |
| Parolini, M | 1 |
| Chinellato, E | 1 |
| Tamburin, S | 1 |
| Polati, E | 1 |
| Dickison, P | 1 |
| Smith, SD | 1 |
| Zhu, X | 1 |
| Li, F | 1 |
| Peng, X | 1 |
| Zeng, K | 1 |
| Sanaei-Zadeh, H | 1 |
| Guarienti, F | 1 |
| Caumo, W | 1 |
| Shiozawa, P | 1 |
| Cordeiro, Q | 1 |
| Boggio, PS | 1 |
| Benseñor, IM | 1 |
| Lotufo, PA | 1 |
| Bikson, M | 1 |
| Brunoni, AR | 1 |
| Glennie, DL | 1 |
| Hayward, JE | 1 |
| McKee, DE | 1 |
| Farrell, TJ | 1 |
| Beer, KR | 1 |
| Hitchcock, TM | 1 |
| Dobke, MK | 1 |
| Akinturk, S | 1 |
| Eroglu, A | 1 |
| Shavit, I | 1 |
| Hadash, A | 1 |
| Knaani-Levinz, H | 1 |
| Shachor-Meyouhas, Y | 1 |
| Kassis, I | 1 |
| Wilhelm, IR | 1 |
| Tzabazis, A | 1 |
| Likar, R | 1 |
| Sittl, R | 1 |
| Griessinger, N | 1 |
| Cilurzo, F | 1 |
| Minghetti, P | 1 |
| Gennari, CG | 1 |
| Casiraghi, A | 1 |
| Montanari, L | 1 |
| Lupo, MP | 1 |
| Swetman, G | 1 |
| Waller, W | 1 |
| Glück, J | 1 |
| Rymarczyk, B | 1 |
| Rogala, B | 1 |
| Kawamata, M | 1 |
| Watanabe, H | 1 |
| Nishikawa, K | 1 |
| Takahashi, T | 1 |
| Kozuka, Y | 1 |
| Kawamata, T | 1 |
| Omote, K | 1 |
| Namiki, A | 1 |
| Gammaitoni, AR | 2 |
| Alvarez, NA | 1 |
| Galer, BS | 1 |
| Haderer, A | 1 |
| Gerner, P | 1 |
| Kao, G | 1 |
| Srinivasa, V | 1 |
| Wang, GK | 1 |
| Fasting, S | 1 |
| Gisvold, SE | 1 |
| Dutta, A | 1 |
| Puri, GD | 1 |
| Wig, J | 1 |
| Moppett, IK | 1 |
| Szypula, K | 1 |
| Yeoman, PM | 1 |
| Koppert, W | 1 |
| Brueckl, V | 1 |
| Weidner, C | 1 |
| Schmelz, M | 1 |
| Migdal, M | 1 |
| Chudzynska-Pomianowska, E | 1 |
| Vause, E | 1 |
| Henry, E | 1 |
| Lazar, J | 1 |
| Skarbek-Borowska, S | 1 |
| Becker, BM | 1 |
| Lovgren, K | 1 |
| Bates, A | 1 |
| Minugh, PA | 1 |
| Ogden, L | 1 |
| Love, G | 1 |
| Basta, S | 1 |
| Lederman, DA | 1 |
| Freedman, PD | 1 |
| Kerpel, SM | 1 |
| Lumerman, H | 1 |
| Lawson, RA | 1 |
| Smart, NG | 1 |
| Gudgeon, AC | 1 |
| Morton, NS | 1 |
| Jackson, D | 1 |
| Chen, AH | 1 |
| Bennett, CR | 1 |
| Rowbotham, MC | 1 |
| Davies, PS | 1 |
| Fields, HL | 1 |
| Oshima, T | 1 |
| Kashiki, K | 1 |
| Toyooka, H | 1 |
| Masuda, A | 1 |
| Amaha, K | 1 |
| Sharara, AM | 1 |
| Higham, MA | 1 |
| Iredale, MJ | 1 |
| Ind, PW | 1 |
| Groth, L | 1 |
| Serup, J | 1 |
| Hewitt, T | 1 |
| Scales, K | 1 |
| Martínez-Tellería, A | 1 |
| Cano Serrano, ME | 1 |
| Rufino Ruiz, J | 1 |
| Mattsson, U | 2 |
| Cassuto, J | 2 |
| Jontell, M | 2 |
| Jönsson, A | 2 |
| Sinclair, R | 1 |
| Tarnow, P | 2 |
| Khatri, KA | 1 |
| Machado, A | 1 |
| Magro, C | 1 |
| Davenport, S | 1 |
| Davis, MW | 1 |
| Dong, H | 1 |
| Kerl, H | 1 |
| Cerroni, L | 1 |
| Nakai, S | 1 |
| Iikura, Y | 1 |
| Akimoto, K | 1 |
| Shiraki, K | 1 |
| Monteiro-Riviere, NA | 1 |
| Villada, G | 1 |
| Zetlaoui, J | 1 |
| Revuz, J | 1 |
| Bjerring, P | 1 |
| Andersen, PH | 1 |
| Arendt-Nielsen, L | 1 |
| Soschin, D | 1 |
| Leyden, JJ | 1 |
| Wuepper, KD | 1 |
| Bokisch, VA | 1 |
| Müller-Eberhard, HJ | 1 |
| Stoughton, RB | 1 |
| Greaves, MW | 1 |
| Birkett, D | 1 |
| Johnson, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison Between the Effects of Lidocaine Prilocaine Cream and Lidocaine Injection on Reduction of Perineal Pain During Episiotomy and Perineum Repair in Vaginal Delivery: Randomized Control Trial[NCT05891132] | 60 participants (Anticipated) | Interventional | 2023-09-01 | Not yet recruiting | |||
| Randomized Double Blind Clinical Trial on the Effect of Levobupivacaine Infiltration Versus Placebo on the Post Partum Perineal Pain in Episiotomy in Primiparous Women After Instrumental Delivery[NCT02796547] | Phase 2 | 0 participants (Actual) | Interventional | 2016-07-14 | Withdrawn (stopped due to Lack of human ressources) | ||
| A Randomized Controlled Trial of Lidocaine Patch for Lower Limb Amputation Pain[NCT02696720] | Phase 2 | 0 participants (Actual) | Interventional | 2016-05-13 | Withdrawn (stopped due to Lack of recruitment) | ||
| Diode Laser as a Biomarker for Neuropathic Pain of Peripheral Origin.[NCT06030297] | 301 participants (Anticipated) | Interventional | 2022-11-01 | Recruiting | |||
| Lidocaine Patches Prior to Percutaneous Nerve Evaluation[NCT05783219] | Phase 2 | 34 participants (Anticipated) | Interventional | 2023-05-01 | Recruiting | ||
| Antipruritic Effect of Topical Ketamine, Amitriptyline, and Lidocaine[NCT03096444] | Phase 2 | 13 participants (Actual) | Interventional | 2017-05-23 | Terminated (stopped due to Efficacy was not seen after interim analysis) | ||
| The PATCH Trial: Effectiveness and Safety of 5% Lidocaine-medicated Plaster for the Treatment of Trigeminal Neuralgia[NCT04570293] | Phase 4 | 226 participants (Actual) | Interventional | 2021-05-01 | Completed | ||
| A Comparison of Amethocaine Creams Versus Liposomal Lidocaine Cream as Pain Reliever Prior to Venipuncture in Children at the Paediatric Emergency Department.[NCT00353002] | 0 participants (Actual) | Interventional | 2006-07-31 | Withdrawn | |||
| The Efficacy of the Eutectic Mixture of Local Anesthetics (EMLA) Cream Versus the Synera Patch for Pain Reduction During Venipuncture in Children[NCT00530803] | Phase 2 | 100 participants (Actual) | Interventional | 2007-06-30 | Completed | ||
| Maternal-Fetal Monitoring of Patients With Rheumatic Heart Disease During Dental Procedure Under Local Anesthesia[NCT00482573] | Phase 1 | 31 participants (Actual) | Interventional | 2004-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"Peak itch intensity between the vehicle and 4 other active treatments (individual ketamine, amitriptyline, or lidocaine, and KeAmLi-combo). Itch intensity was measured on a 100mm scale visual analog scale for 10 minutes. 0 was weighted with no itch and 100 was weighted with most itch imaginable." (NCT03096444)
Timeframe: 10 minutes
| Intervention | Intensity score (Mean) |
|---|---|
| Topical KeAmLi Combo | 62.7 |
| Topical Ketamine | 63.1 |
| Topical Amitriptyline | 69.2 |
| Topical Lidocaine | 65.8 |
| Topical Vehicle | 61.9 |
Assess mechanical detection and pain thresholds using von Frey filaments stimulators (measured in force mN) to calculate the final threshold as the geometric mean of five series of ascending and descending stimuli. (NCT03096444)
Timeframe: 5 minutes
| Intervention | mN (Mean) | |
|---|---|---|
| Mechanical Detection Threshold | Mechanical Pain Threshold | |
| Topical Amitriptyline | 3.573423965 | 152.4768146 |
| Topical KeAmLi Combo | 3.519376956 | 152.3293608 |
| Topical Ketamine | 3.464204768 | 135.9 |
| Topical Lidocaine | 3.546037659 | 126.9 |
| Topical Vehicle | 3.525692637 | 148.7138273 |
Two standardized quantitative sensory tests are performed to measure warmth detection threshold (assesses the threshold of which warmth sensation is first detected) and heat pain threshold (assesses the threshold at which heat pain sensation is first detected). Measured in change in celsius. (NCT03096444)
Timeframe: 3 minutes
| Intervention | Degrees celsius (Mean) | |
|---|---|---|
| Warm Detection Threshold | Heat Pain Threshold | |
| Topical Amitriptyline | 33.9 | 40.0 |
| Topical KeAmLi Combo | 33.6 | 39.8 |
| Topical Ketamine | 34.0 | 40.0 |
| Topical Lidocaine | 33.7 | 39.4 |
| Topical Vehicle | 33.8 | 39.7 |
The NRS (Numerical Rating Scale) is a 6-point rating scale where 0= no pain and 5 = worst pain. Blinded observers reported their own subjective evaluation of the level of pain experienced by the participants at tourniquet placement. Total number of participants subjectively evaluated as experiencing each pain level is reported. (NCT00530803)
Timeframe: before venipuncture
| Intervention | Participants (Count of Participants) | |||||
|---|---|---|---|---|---|---|
| Participants evaluated at NRS = 0 (No pain) | Participants evaluated at NRS = 1 | Participants evaluated at NRS = 2 | Participants evaluated at NRS = 3 | Participants evaluated at NRS = 4 | Participants evaluated at NRS = 5 | |
| EMLA Cream | 41 | 6 | 2 | 1 | 0 | 0 |
| Synera Patch | 37 | 6 | 5 | 1 | 1 | 0 |
The NRS (Numerical Rating Scale) is a 6-point rating scale where 0= no pain and 5 = worst pain. Blinded observers reported their own subjective evaluation of the level of pain participants were experiencing 5 minutes after the venipuncture was completed. Total number of participants subjectively evaluated as experiencing each pain level is reported. (NCT00530803)
Timeframe: 5 minutes post venipuncture
| Intervention | Participants (Count of Participants) | |||||
|---|---|---|---|---|---|---|
| Participants evaluated at NRS = 0 (No pain) | Participants evaluated at NRS = 1 | Participants evaluated at NRS = 2 | Participants evaluated at NRS = 3 | Participants evaluated at NRS = 4 | Participants evaluated at NRS = 5 | |
| EMLA Cream | 45 | 3 | 1 | 1 | 0 | 0 |
| Synera Patch | 45 | 4 | 1 | 0 | 0 | 0 |
The NRS (Numerical Rating Scale) is a 6-point rating scale where 0= no pain and 5 = worst pain. Blinded observers reported their own subjective evaluation of the level of pain experienced by the participants at needle insertion. Total number of participants subjectively evaluated as experiencing each pain level is reported. (NCT00530803)
Timeframe: during needle insertion
| Intervention | Participants (Count of Participants) | |||||
|---|---|---|---|---|---|---|
| Participants evaluated at NRS = 0 (No pain) | Participants evaluated at NRS = 1 | Participants evaluated at NRS = 2 | Participants evaluated at NRS = 3 | Participants evaluated at NRS = 4 | Participants evaluated at NRS = 5 | |
| EMLA Cream | 32 | 14 | 2 | 2 | 0 | 0 |
| Synera Patch | 25 | 12 | 9 | 2 | 2 | 0 |
The Numerical Rating Scale (NRS) is a 6-point rating scale where 0= no pain and 5 = worst pain. Parents reported their own subjective evaluation of participants pain level. Each participant had only one parental assessment. Total number of parental assessment for each pain level on the 6-point NRS is reported as total number of participants experiencing that pain level. (NCT00530803)
Timeframe: immediately after venipuncture is completed
| Intervention | Participants (Count of Participants) | |||||
|---|---|---|---|---|---|---|
| number of participants with NRS=0 (no pain) | number of participants with NRS=1 | number of participants with NRS=2 | number of participants with NRS=3 | number of participants with NRS=4 | number of participants with NRS=5 | |
| EMLA Cream | 42 | 6 | 1 | 1 | 0 | 0 |
| Synera Patch | 41 | 5 | 1 | 2 | 0 | 1 |
"Participants were asked to report their level of pain using a 6-point Wong-Baker FACES Pain Rating Scale ranging from 0, no pain, to 5, the most pain you can have. The Wong-Baker FACES Pain Rating Scale is a validated tool for measuring pain in patients as young as 3 years old. A FACES pain score less than or equal to 2 is considered no pain to mild pain, and is clinically acceptable. Studies have shown average FACES pain scores for children receiving vascular access with placebo to be 2.2 to 3.5." (NCT00530803)
Timeframe: immediately after completion of venipuncture
| Intervention | Participants (Count of Participants) | |||||
|---|---|---|---|---|---|---|
| Participants with FACES Score = 0 (No pain) | Participants with FACES Score = 1 | Participants with FACES Score = 2 | Participants with FACES Score = 3 | Participants with FACES Score = 4 | Participants with FACES Score = 5 | |
| EMLA Cream | 42 | 6 | 2 | 0 | 0 | 0 |
| Synera Patch | 38 | 8 | 3 | 1 | 0 | 0 |
1 review available for lidocaine and Erythema
| Article | Year |
|---|---|
Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature.
Topics: Administration, Cutaneous; Aged; Analgesia; Area Under Curve; Biological Availability; Clinical Tria | 2003 |
Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature.
Topics: Administration, Cutaneous; Aged; Analgesia; Area Under Curve; Biological Availability; Clinical Tria | 2003 |
Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature.
Topics: Administration, Cutaneous; Aged; Analgesia; Area Under Curve; Biological Availability; Clinical Tria | 2003 |
Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature.
Topics: Administration, Cutaneous; Aged; Analgesia; Area Under Curve; Biological Availability; Clinical Tria | 2003 |
Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature.
Topics: Administration, Cutaneous; Aged; Analgesia; Area Under Curve; Biological Availability; Clinical Tria | 2003 |
Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature.
Topics: Administration, Cutaneous; Aged; Analgesia; Area Under Curve; Biological Availability; Clinical Tria | 2003 |
Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature.
Topics: Administration, Cutaneous; Aged; Analgesia; Area Under Curve; Biological Availability; Clinical Tria | 2003 |
Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature.
Topics: Administration, Cutaneous; Aged; Analgesia; Area Under Curve; Biological Availability; Clinical Tria | 2003 |
Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature.
Topics: Administration, Cutaneous; Aged; Analgesia; Area Under Curve; Biological Availability; Clinical Tria | 2003 |
Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature.
Topics: Administration, Cutaneous; Aged; Analgesia; Area Under Curve; Biological Availability; Clinical Tria | 2003 |
Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature.
Topics: Administration, Cutaneous; Aged; Analgesia; Area Under Curve; Biological Availability; Clinical Tria | 2003 |
Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature.
Topics: Administration, Cutaneous; Aged; Analgesia; Area Under Curve; Biological Availability; Clinical Tria | 2003 |
Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature.
Topics: Administration, Cutaneous; Aged; Analgesia; Area Under Curve; Biological Availability; Clinical Tria | 2003 |
Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature.
Topics: Administration, Cutaneous; Aged; Analgesia; Area Under Curve; Biological Availability; Clinical Tria | 2003 |
Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature.
Topics: Administration, Cutaneous; Aged; Analgesia; Area Under Curve; Biological Availability; Clinical Tria | 2003 |
Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature.
Topics: Administration, Cutaneous; Aged; Analgesia; Area Under Curve; Biological Availability; Clinical Tria | 2003 |
Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature.
Topics: Administration, Cutaneous; Aged; Analgesia; Area Under Curve; Biological Availability; Clinical Tria | 2003 |
Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature.
Topics: Administration, Cutaneous; Aged; Analgesia; Area Under Curve; Biological Availability; Clinical Tria | 2003 |
Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature.
Topics: Administration, Cutaneous; Aged; Analgesia; Area Under Curve; Biological Availability; Clinical Tria | 2003 |
Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature.
Topics: Administration, Cutaneous; Aged; Analgesia; Area Under Curve; Biological Availability; Clinical Tria | 2003 |
Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature.
Topics: Administration, Cutaneous; Aged; Analgesia; Area Under Curve; Biological Availability; Clinical Tria | 2003 |
Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature.
Topics: Administration, Cutaneous; Aged; Analgesia; Area Under Curve; Biological Availability; Clinical Tria | 2003 |
Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature.
Topics: Administration, Cutaneous; Aged; Analgesia; Area Under Curve; Biological Availability; Clinical Tria | 2003 |
Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature.
Topics: Administration, Cutaneous; Aged; Analgesia; Area Under Curve; Biological Availability; Clinical Tria | 2003 |
Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature.
Topics: Administration, Cutaneous; Aged; Analgesia; Area Under Curve; Biological Availability; Clinical Tria | 2003 |
23 trials available for lidocaine and Erythema
| Article | Year |
|---|---|
Reducing transcranial direct current stimulation-induced erythema with skin pretreatment: considerations for sham-controlled clinical trials.
Topics: Administration, Cutaneous; Adult; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Antip | 2015 |
Safety and effectiveness of injection of calcium hydroxylapatite via blunt cannula compared to injection by needle for correction of nasolabial folds.
Topics: Aged; Anesthetics, Local; Catheters; Contusions; Cosmetic Techniques; Durapatite; Edema; Erythema; F | 2014 |
A clinical comparison of topical piroxicam and EMLA cream for pain relief and inflammation in laser hair removal.
Topics: Administration, Topical; Adolescent; Adult; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroi | 2009 |
Lidocaine-based topical anesthetic with disinfectant (LidoDin) versus EMLA for venipuncture: a randomized controlled trial.
Topics: Adolescent; Adult; Anesthetics, Combined; Anesthetics, Local; Child; Disinfectants; Edema; Erythema; | 2009 |
Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Anesthetics, Local; Data Collection; Eryt | 2010 |
The effect of lidocaine when mixed with large gel particle hyaluronic acid filler tolerability and longevity: a six-month trial.
Topics: Adult; Aged; Anesthetics, Local; Biocompatible Materials; Contusions; Cosmetic Techniques; Double-Bl | 2010 |
Different mechanisms of development and maintenance of experimental incision-induced hyperalgesia in human skin.
Topics: Adult; Anesthetics, Local; Double-Blind Method; Erythema; Female; Forearm; Humans; Hyperalgesia; Lid | 2002 |
Statistical process control methods allow the analysis and improvement of anesthesia care.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents, Non-Steroidal; Catheterization, Peripheral | 2003 |
Piroxicam gel, compared to EMLA cream is associated with less pain after venous cannulation in volunteers.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents, Non-Steroidal; Catheterization, Peripheral | 2003 |
Comparison of EMLA and lidocaine iontophoresis for cannulation analgesia.
Topics: Adult; Aged; Analgesia; Anesthetics, Combined; Anesthetics, Local; Catheterization, Peripheral; Doub | 2004 |
Mechanically induced axon reflex and hyperalgesia in human UV-B burn are reduced by systemic lidocaine.
Topics: Adult; Axons; Burns; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug | 2004 |
Rapid, needle-free delivery of lidocaine for reducing the pain of venipuncture among pediatric subjects.
Topics: Adolescent; Anesthetics, Local; Child; Child, Preschool; Double-Blind Method; Erythema; Female; Huma | 2005 |
Brief focal ultrasound with topical anesthetic decreases the pain of intravenous placement in children.
Topics: Administration, Topical; Adolescent; Anesthetics, Local; Attitude of Health Personnel; Catheterizati | 2006 |
Systemic exposure to lidocaine and tetracaine is low after an application of a lidocaine 7%-tetracaine 7% peel in adults.
Topics: Administration, Topical; Adult; Anesthetics, Local; Area Under Curve; Drug Combinations; Erythema; F | 2008 |
Evaluation of an amethocaine gel preparation for percutaneous analgesia before venous cannulation in children.
Topics: Administration, Cutaneous; Anesthetics, Local; Catheterization, Peripheral; Child; Child, Preschool; | 1995 |
Evaluation of an amethocaine gel preparation for percutaneous analgesia before venous cannulation in children.
Topics: Administration, Cutaneous; Anesthetics, Local; Catheterization, Peripheral; Child; Child, Preschool; | 1995 |
Evaluation of an amethocaine gel preparation for percutaneous analgesia before venous cannulation in children.
Topics: Administration, Cutaneous; Anesthetics, Local; Catheterization, Peripheral; Child; Child, Preschool; | 1995 |
Evaluation of an amethocaine gel preparation for percutaneous analgesia before venous cannulation in children.
Topics: Administration, Cutaneous; Anesthetics, Local; Catheterization, Peripheral; Child; Child, Preschool; | 1995 |
Topical lidocaine gel relieves postherpetic neuralgia.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Blood Pressure; Double-Blind Method; Erythema; F | 1995 |
Cutaneous iontophoretic application of condensed lidocaine.
Topics: Administration, Cutaneous; Adult; Anesthesia, Local; Erythema; Female; Forearm; Humans; Iontophoresi | 1994 |
Intradermal actions of hypertonic saline involve neural and vascular mechanisms.
Topics: Anesthetics, Local; Double-Blind Method; Drug Interactions; Edema; Erythema; Forearm; Histamine; Hum | 1995 |
[Efficacy of EMLA cream, effect of time and place of application].
Topics: Adult; Anesthetics, Combined; Anesthetics, Local; Double-Blind Method; Elbow; Emulsions; Erythema; F | 1999 |
Digital image analysis of erythema development after experimental thermal injury to human skin: effect of postburn topical local anesthetics (EMLA).
Topics: Administration, Topical; Adult; Anesthetics, Combined; Anesthetics, Local; Burns; Erythema; Humans; | 1999 |
Intravenous lidocaine infusion in the treatment of experimental human skin burns - digital colour image analysis of erythema development.
Topics: Adult; Anesthetics, Local; Burns; Cross-Sectional Studies; Dose-Response Relationship, Drug; Double- | 2000 |
Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing.
Topics: Administration, Topical; Anesthetics, Local; Delayed-Action Preparations; Edema; Erythema; Female; H | 2002 |
Local blanching after epicutaneous application of EMLA cream. A double-blind randomized study among 50 healthy volunteers.
Topics: Administration, Cutaneous; Anesthetics, Local; Double-Blind Method; Drug Combinations; Erythema; Hum | 1990 |
24 other studies available for lidocaine and Erythema
| Article | Year |
|---|---|
Dermal effects and pharmacokinetic evaluation of the lidocaine/prilocaine cream in healthy Chinese volunteers.
Topics: Anesthetics, Local; Drug Combinations; East Asian People; Erythema; Healthy Volunteers; Humans; Lido | 2023 |
The Efficacy of Pulsed Dye Laser Pretreated With or Without Local Anesthetic on Patients Presenting With Erythema of Face, Neck, Chest, and Extremities.
Topics: Adult; Anesthetics, Local; Erythema; Female; Humans; Lasers, Dye; Lidocaine; Low-Level Light Therapy | 2020 |
Topical brimonidine gel for extended-duration local anaesthesia.
Topics: Adrenergic alpha-2 Receptor Agonists; Anesthesia, Local; Anesthetics, Local; Brimonidine Tartrate; E | 2018 |
Efficacy of lidocaine 5% medicated plaster (VERSATIS®) in patients with localized neuropathic pain poorly responsive to pharmacological therapy.
Topics: Aged; Analgesics; Anesthetics, Local; Drug Evaluation; Drug Resistance; Drug Therapy, Combination; E | 2018 |
Biting down on the truth: A case of a delayed hypersensitivity reaction to lidocaine.
Topics: Aged; Anesthetics, Local; Drug Eruptions; Erythema; Humans; Hypersensitivity, Delayed; Lidocaine; Ma | 2019 |
Formulation and evaluation of lidocaine base ethosomes for transdermal delivery.
Topics: Administration, Cutaneous; Anesthetics, Local; Animals; Chemistry, Pharmaceutical; Cholesterol; Chro | 2013 |
Centipede bite.
Topics: Aged; Analgesics, Opioid; Anesthetics, Local; Animals; Anti-Allergic Agents; Anti-Inflammatory Agent | 2014 |
Inexpensive diffuse reflectance spectroscopy system for measuring changes in tissue optical properties.
Topics: Epinephrine; Erythema; Humans; Lidocaine; Optical Imaging; Skin; Spectrum Analysis | 2014 |
Review of the safety profile for microfocused ultrasound with visualization.
Topics: Anesthetics, Local; Clinical Trials as Topic; Contusions; Edema; Erythema; Humans; Lidocaine; Produc | 2014 |
A novel polymethylmethacrylate hydrophilic adhesive matrix intended for transdermal patch formulations.
Topics: Adhesiveness; Adhesives; Administration, Cutaneous; Adult; Anesthetics, Local; Biopharmaceutics; Che | 2010 |
An immediate hypersensitivity reaction caused by tolperisone hydrochloride.
Topics: Drug Hypersensitivity; Edema; Erythema; Humans; Lidocaine; Male; Middle Aged; Muscle Relaxants, Cent | 2011 |
Cutaneous analgesia after transdermal application of amitriptyline versus lidocaine in rats.
Topics: Administration, Cutaneous; Amitriptyline; Analgesics; Anesthetics, Local; Animals; Antidepressive Ag | 2003 |
An unusual skin reaction following local anesthetic injection. Review of the literature and report of four cases.
Topics: Arthus Reaction; Child; Drug Eruptions; Drug Hypersensitivity; Drug Tolerance; Erythema; Female; Hum | 1980 |
Identifying true lidocaine allergy.
Topics: Anesthesia, Dental; Anesthesia, Local; Dental Anxiety; Diagnosis, Differential; Drug Hypersensitivit | 1994 |
Identifying true lidocaine allergy.
Topics: Anesthesia, Dental; Anesthesia, Local; Dental Anxiety; Diagnosis, Differential; Drug Hypersensitivit | 1994 |
Identifying true lidocaine allergy.
Topics: Anesthesia, Dental; Anesthesia, Local; Dental Anxiety; Diagnosis, Differential; Drug Hypersensitivit | 1994 |
Identifying true lidocaine allergy.
Topics: Anesthesia, Dental; Anesthesia, Local; Dental Anxiety; Diagnosis, Differential; Drug Hypersensitivit | 1994 |
Cutaneous microdialysis in man: effects of needle insertion trauma and anaesthesia on skin perfusion, erythema and skin thickness.
Topics: Administration, Cutaneous; Anesthetics, Local; Erythema; Female; Humans; Lidocaine; Male; Microdialy | 1998 |
Prolonged contact with topical anaesthetic cream: a case report.
Topics: Administration, Topical; Anesthetics, Local; Erythema; Humans; Infant; Lidocaine; Lidocaine, Priloca | 1998 |
Laser peel: facial rejuvenation with a superficial erbium:YAG laser treatment.
Topics: Adult; Aged; Anesthetics, Local; Erbium; Erythema; Female; Humans; Laser Therapy; Lidocaine; Lidocai | 2000 |
EMLA cream-induced irritant contact dermatitis.
Topics: Acrodermatitis; Administration, Topical; Anesthetics, Local; Child; Dermatitis, Contact; Diagnosis, | 2002 |
Substance p-induced cutaneous and bronchial reactions in children with bronchial asthma.
Topics: Adolescent; Adult; Asthma; Bronchial Provocation Tests; Child; Child, Preschool; Erythema; Female; F | 1991 |
Altered epidermal morphology secondary to lidocaine iontophoresis: in vivo and in vitro studies in porcine skin.
Topics: Administration, Cutaneous; Animals; Erythema; Female; In Vitro Techniques; Iontophoresis; Lidocaine; | 1990 |
Vascular response of human skin after analgesia with EMLA cream.
Topics: Adult; Analgesia; Anesthetics, Local; Drug Combinations; Drug Eruptions; Erythema; Female; Humans; L | 1989 |
Sorbic acid-induced erythema and edema.
Topics: Administration, Topical; Anti-Inflammatory Agents; Aspirin; Betamethasone Valerate; Capsaicin; Cosme | 1986 |
Cutaneous responses to human C 3 anaphylatoxin in man.
Topics: Biopsy; Cell Movement; Complement System Proteins; Erythema; Histamine; Histamine H1 Antagonists; Hi | 1972 |
Nevus anemicus: a unique catecholamine-dependent nevus.
Topics: Administration, Oral; Adolescent; Adult; Anemia; Angiokeratoma; Blood Vessels; Bradykinin; Capillari | 1970 |